Determinants of humoral immune response to SARS-CoV-2 vaccines in solid cancer patients: A systematic review and meta-analysis.

Wankhede, Durgesh; Grover, Sandeep; Hofman, Paul

Wankhede, Durgesh; Grover, Sandeep; Hofman, Paul.

Afiliação

Wankhede D; Department of Surgical Oncology, All India Institute of Medical Sciences, New Delhi, India. Electronic address: drdurgeshwankhede@gmail.com.
Grover S; Center for Human Genetics, Universitatsklinikum Giessen und Marburg - Standort Marburg, 35055 Marburg, Germany.
Hofman P; Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, University Côte d'Azur, 30 avenue de la voie romaine, 06002 Nice, France; Institute for Research on Cancer and Ageing, Nice (IRCAN), INSERM U1081 and UMR CNRS 7284, Team 4, Nice, France; Hospital-Integrated Biobank BB-0033-00025, Pasteur Hospital, Nice, France; University Hospital Federation OncoAge, CHU de Nice, University Côte d'Azur, Nice, France.

Vaccine ; 41(11): 1791-1798, 2023 03 10.

Article em En | MEDLINE | ID: mdl-36792435

Assuntos

COVID-19; Neoplasias; Adulto; Humanos; Masculino; Idoso; Vacinas contra COVID-19/uso terapêutico; Imunidade Humoral; Estudos Prospectivos; Estudos Retrospectivos; COVID-19/prevenção & controle; SARS-CoV-2; Neoplasias/terapia; Anticorpos Antivirais; Vacinação

Palavras-chave

COVID-19; COVID-19 vaccines; Cancer; Seroconversion

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Aged / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google